Evidence map›Paper›PMID 26478445›Full record

ArticleJournal of veterinary internal medicine

Association of Gallbladder Mucocele Histologic Diagnosis with Selected Drug Use in Dogs: A Matched Case-Control Study.

J L Gookin, M T Correa, A Peters, A Malueg, K G Mathews, J Cullen, G Seiler

Open access · goldAbstract read
In one paragraph

Article in Journal of veterinary internal medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Gall bladder mucoceles in Border terriers.Journal of veterinary internal medicine · 2018
    Article
  12. Article
  13. Observational
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J L GookinDepartment of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.
M T CorreaPopulation Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.
A PetersThe Veterinary Hospital, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.
A MaluegThe Veterinary Hospital, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.
K G MathewsDepartment of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.
J CullenPopulation Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.
G SeilerMolecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.
North Carolina State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe cause of gallbladder mucocele (GBM) formation in dogs currently is unknown. Many available drugs represent a newer generation of xenobiotics that may predispose dogs to GBM formation.

objectiveTo determine if there is an association between the histologic diagnosis of GBM in dogs and administration of selected drugs. ANIMALS: Eighty-one dogs with a histologic diagnosis of GBM and 162 breed, age, and admission date-matched control dogs from a single referral institution.

methodsMedical records of dogs with GBM and control dogs from 2001 to 2011 were reviewed. Owner verification of drug history was sought by a standard questionnaire. Reported use of heartworm, flea, and tick preventatives as well as nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, or medications for treatment of osteoarthritis was recorded.

resultsDogs with GBM were 2.2 times as likely to have had reported use of thyroxine (as a proxy for the diagnosis of hypothyroidism) as control dogs (95% confidence interval [CI], 0.949-5.051), 3.6 times as likely to have had reported treatment for Cushing's disease (95% CI, 1.228-10.612), and 2.3 times as likely to have had reported use of products containing imidacloprid (95% CI, 1.094-4.723). Analysis of a data subset containing only Shetland sheepdogs (23 GBM and 46 control) indicated that Shetland sheepdogs with GBM formation were 9.3 times as likely to have had reported use of imidacloprid as were control Shetland sheepdogs (95% CI, 1.103-78.239). CONCLUSIONS AND CLINICAL IMPORTANCE: This study provides evidence for an association between selected drug use and GBM formation in dogs. A larger epidemiologic study of Shetland sheepdogs with GBM formation and exposure to imidacloprid is warranted.

Indexed as

AnimalsCase-Control StudiesCholinergic AgentsDog DiseasesDogsFemaleGallbladder DiseasesHypothyroidismImidazolesMaleMucoceleNeonicotinoidsNitro CompoundsPituitary ACTH HypersecretionRisk FactorsThyroxineCholinergic AgentsimidaclopridImidazolesNeonicotinoidsNitro CompoundsThyroxineBileCanineMucusXenobiotic

Identifiers

PMID26478445
PMCPMC4895658
OpenAlexW2118170624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.